Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Specific abnormal clinical presentations require targeted interventions to mitigate their impact on daily functioning
10.1016/j.tiv.2012.01.013 Toxicol
K., Majumder, P
The guideline addresses the evaluation, management, and monitoring of individuals with lipid disorders, including high blood cholesterol, hypertriglyceridemia, and elevated Lp(a), incorporating new and updated recommendations based on clinical evidence through late 2024
Although randomized controlled studies provide high-quality evidence, retrospective cohort studies have serious limitations due to inadequate data on confounding factors
doi: 10.1038/s41419-021-03930-2 66 ZhangXLiangZZhouYWangFWeiSTanBet al
US$ 21.36
US$ 26.02
US$ 26.51
